Key points are not available for this paper at this time.
In the quest for effective and holistic therapies for the growing burden of gastrointestinal illnesses, IBS has emerged as a major concern. This integrative review, "Takra: An integrative review on its efficacy in irritable bowel syndrome," examines whether Takra (buttermilk), a fermented dairy product, can treat IBS. The human gut, a dynamic ecology of microbes, is essential to health. New research has shown that gut health affects everything from immunity to mental health. IBS, a persistent functional gastrointestinal illness that causes abdominal pain and bloating and changes bowel patterns, burdens sufferers and healthcare systems worldwide. Takra (buttermilk or chaas) has a long history in traditional medicine, particularly in Ayurveda, which was used to treat digestive issues like Grahani roga (Malabsorption syndrome). Its fermentation process gives it probiotic characteristics, making it ideal for gastrointestinal ailments. This extensive analysis evaluates clinical and preclinical data to determine if Takra (buttermilk) can treat IBS. Historical use, mechanisms of action, clinical evidence, and safety are studied. The results of this review imply that Takra (buttermilk) may be a promising natural and culturally rooted IBS supplement. This article discusses Takra (buttermilk), the ancient elixir, and its potential to improve gut health, treat IBS, and improve the quality of life as the global healthcare landscape evolves towards integrative and holistic treatments.
Keshri et al. (Thu,) studied this question.